ERA-EDTA Congress 2011: Late Breaking Clinical Trials I PR Newswire (press release) in four different groups. Significant improvements in GFR were reported in all the bardoxolone groups compared to the placebo group (p<0.001). Other renal function parameters (creatinine and urea) were also better in the Bardoxolone group. and more »

...